Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
50 /100
MEDIUM RISK
Score updated Oct 13, 2026

SKYE — Skye Bioscience, Inc. Dilution Risk Tracker

Track SKYE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SKYE — Get alerts when the score changes →

As of October 13, 2026, Skye Bioscience, Inc. (SKYE) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. Skye Bioscience, Inc. has a market capitalization of $55.97M, 35.42M shares outstanding, 41 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
85
📊 Float Risk
22
⚠️ Warrant Exposure
40
🔄 Convertible Debt
15

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 45%
🔄 Reverse Split model est. 70%
• 50-day avg $0.78 below $1 exchange minimum
• Only 5 months cash — financial pressure
💰 Capital Raise model 35%
• Low cash runway: 5 months remaining
🔔 Track SKYE — Get forecast alerts →

Market Data

Market Cap$55.97M
Shares Outstanding35.42M
Float22.96M
Cash$10.06M
Debt$116.7K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore50/100DilutionWatch score record
Shares Outstanding35.42MVerified float table or market cache
Public Float22.96MVerified float table or market cache
Market Cap$55.97MMarket data cache
Cash Runway4.6 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 6.4% shares (2026Q1 vs prior)
41 institutional holders · 17.25M shares
#1 5AM Venture Management, LLC 9.68M shares
#2 Versant Venture Management, LLC 2.01M shares
#3 BAKER BROS. ADVISORS LP 1.58M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest148.0K
Days to Cover1.7
% of Float0.6%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-10
xbrl XBRL WARRANT 2025-03-20
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual SKYE Dilution Snapshot

Skye Bioscience, Inc. (SKYE) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

SKYE's DilutionScore is currently 50/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 43/100 (Medium risk).

Period Score Risk Level Duration
Aug 14 – Oct 13, 202650/100MEDIUM60 days
Jul 16 – Aug 13, 202643/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

SKYE shares outstanding have increased 9.6% from 32.06M (Mar 2026) to 35.14M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 13, 202635.14M22.96M▲ 5.29%
Apr 26, 202635.13M21.81M▲ 2.86%
Mar 14, 202632.06M21.20M▲ 2.43%
Mar 13, 202632.06M20.70M▲ 4.12%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track SKYE Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment SKYE files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking SKYE — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for SKYE
SKYE FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.